Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 23200914)

1.

High level of chromosomal aberration in ovarian cancer genome correlates with poor clinical outcome.

Cope L, Wu RC, Shih IeM, Wang TL.

Gynecol Oncol. 2013 Mar;128(3):500-5. doi: 10.1016/j.ygyno.2012.11.031. Epub 2012 Nov 28.

2.

The changing view of high-grade serous ovarian cancer.

Berns EM, Bowtell DD.

Cancer Res. 2012 Jun 1;72(11):2701-4. doi: 10.1158/0008-5472.CAN-11-3911. Epub 2012 May 16. Review.

3.

Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles.

May T, Shoni M, Crum CP, Xian W, Vathipadiekal V, Birrer M, Rosen B, Tone A, Murphy KJ.

Gynecol Oncol. 2013 Mar;128(3):488-92. doi: 10.1016/j.ygyno.2012.12.009. Epub 2012 Dec 16. Review.

PMID:
23253401
4.

HMGA2 and high-grade serous ovarian carcinoma.

Wu J, Wei JJ.

J Mol Med (Berl). 2013 Oct;91(10):1155-65. doi: 10.1007/s00109-013-1055-8. Epub 2013 May 19. Review.

PMID:
23686260
5.

Genomic alterations as mediators of miRNA dysregulation in ovarian cancer.

Kan CW, Howell VM, Hahn MA, Marsh DJ.

Genes Chromosomes Cancer. 2015 Jan;54(1):1-19. doi: 10.1002/gcc.22221. Epub 2014 Oct 3. Review.

PMID:
25280227
6.

Key nodes of a microRNA network associated with the integrated mesenchymal subtype of high-grade serous ovarian cancer.

Sun Y, Guo F, Bagnoli M, Xue FX, Sun BC, Shmulevich I, Mezzanzanica D, Chen KX, Sood AK, Yang D, Zhang W.

Chin J Cancer. 2015 Jan;34(1):28-40. doi: 10.5732/cjc.014.10284. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk